LGALS3BP and neuroblastoma: Leveraging its high expression on EVs, Galectin-3 binding protein (LGALS3BP) was targeted by 1959-sss/DM3, a non-internalizing ADC shown to bind EVs effectively and yield therapeutic benefits in NB models.